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lipopolysaccharides	 (LPS)	 injection	 or	 by	 polyethylene	 particles	 (Ceridust)	 mixed	
with	DBBM.	Three	modalities	were	randomly	applied	(n	=	10	each):	(a)	DBBM	alone	
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1  | INTRODUC TION
Knowledge	of	bone	biology	in	conjunction	with	implant	placement	
has	 enormously	 increased	 in	 the	 last	 decades.	 However,	 surpris-
ingly	little	is	known	about	the	dynamics	of	bone	resorption.	Chronic	
inflammation,	 being	 a	 hallmark	 of	 peri‐implantitis	 (Berglundh,	
Gislason,	 Lekholm,	 Sennerby,	 &	 Lindhe,	 2004;	 Lindhe,	 Berglundh,	







on	 the	 resorption	 of	 bone	 substitutes,	 independent	 if	 they	 are	 of	
natural	 or	 synthetic	 origin,	 is	 sparse	 and	 almost	 exclusively	 based	


























Our	 group	 discovered,	 using	 a	 minipig	 augmentation	 model,	
































2  | MATERIAL AND METHODS
2.1 | Study design
The	Medical	University	 of	Vienna	 ethical	 review	board	 for	 animal	
research	approved	the	study	protocol	(GZ	BMWFW‐66.009/0193‐
WF/V/3b/2016‐2016).	 The	 study	 was	 performed	 in	 2017	 at	 the	
Department	 of	 Biomedical	 Research	 of	 the	 Medical	 University	
of	 Vienna	 in	 accordance	with	 the	ARRIVE	 guidelines.	 Thirty	male	
BALB/c	mice	(8–10	weeks,	20–25	g)	from	the	Division	for	Biomedical	








Austria)	by	 intramuscular	 injection.	An	 incision	was	made	over	the	
calvaria.	 The	 periosteum	 was	 elevated	 off	 the	 external	 cortex	 of	




after	 the	DBBM	 (50	mg)	 augmentation	 inflammation	was	 induced	
by	two	local	injection	of	LPS	from	Escherichia coli	serotype	O55:	B5	
(25	mg/kg,	Sigma)	at	day	2	and	day	5	next	to	sagittal	suture	directly	
into	 the	 augmented	 area.	 The	 wounds	 were	 closed	 in	 two	 layers	
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with	resorbable	sutures	(Vicryl	6–0;	Ethicon	GmbH).	For	pain	relief,	
buprenorphine	0.06	mg/kg	 s.c.	 (Temgesic®,	 Temgesic,	 Reckitt	 and	
Colman	Pharm.)	and	piritramide	in	drinking	water	ad	lib	were	admin-
istered.	Mice	were	 euthanized	 on	 day	 fourteen	with	 an	 overdose	
of	sodium	pentobarbital	at	300	mg/kg	i.p.,	and	each	calvarium	was	











varia	 are	 at	 the	 same	position	 and	orientation	 in	 all	 scans.	Region	









(mm3)	 and	 the	 relative	proportion	of	 soft	 tissue	 in	 the	augmented	






















(CI).	 A	 non‐parametric	 approach	was	 used	 for	 inference:	 In	 a	 first	
step,	 an	 ANOVA‐type	 permutation	 test	 was	 calculated	 based	 on	
B	=	10000.	 In	case	of	significance,	pairwise	post	hoc	permutation	
tests	were	performed,	using	the	step‐down	maxT	procedure	to	ac-








3.1 | Catabolic changes of the mouse calvarial bone 





























3.2 | Catabolic changes of the mouse calvarial bone 




LPS	 and	 Ceridust	 caused	 extensive	 resorption	 as	 well	 as	 heavily	
compensatory	endocranial	bone	formation	underneath	the	cortical	





















(Figure	 S2),	 but	 showed	 no	 significant	 differences	 when	 controls	
were	compared	to	LPS	and	Ceridust	groups	(Figure	6).


















F I G U R E  3  Lipopolysaccharides	(LPS)	and	Ceridust	alter	the	cortical	porosity	and	cortical	bone	volume.	Based	on	µCT	data,	cortical	
porosity	(void	volume/tissue	volume,	Vd.V/TV	in	%),	cortical	bone	volume/tissue	volume	(Ct.BV/TV	in	%),	and	cortical	thickness	(Ct.Th	in	
mm)	were	determined.	Lipopolysaccharides	(LPS)	and	Ceridust	caused	an	increase	of	the	Vd.S/TS	with	p < .001 and p	=	.062,	respectively.	
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of	 inflammation	were	strongest	 in	 the	vicinity	of	 the	skin	defects.	
In	the	augmented	areas,	inflammatory	signs	were	weak	and	showed	
no	considerable	differences	between	the	groups.	The	size	of	DBBM	
particles	 seemed	 to	 be	 undiminished.	 Furthermore,	 particle	 size	
and	distribution	appeared	similar	in	all	treatment	groups	(Figure	7).	
Taken	 together,	 even	 though	DBBM	 treated	with	 LPS	or	Ceridust	




The	 results	 presented	 herein	 demonstrate	 that	 LPS	 and	 Ceridust	
cause	 a	 combination	of	 intense	 resorption	 and	 a	 following	 forma-
tional	activity	in	the	mouse	calvaria	bone.	The	size	distribution	and	
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periosteum	using	a	sterile	sharp	surgical	spoon.	After	14	days	post-
operatively,	 quantitative	 µCT	 imaging	 revealed	 an	 approximately	
30%	change	of	osteolysis	that	is	based	on	TNF	signaling	(Merkel	et	
al.,	1999).	Therefore,	our	µCT	and	histological	data	support	previous	





















An	 earlier	 study	 by	 our	 group	 suggested	 that	 DBBM	 is	 re-
sorbable	in	a	pig	calvaria	augmentation	model	under	as	yet	unex-
plained	conditions	(Busenlechner	et	al.,	2012).	It	is	possible	that	an	
inflammatory	 environment	 caused	 the	 underlying	molecular	 and	
cellular	mechanisms	 leading	 to	 resorption	 of	DBBM.	 Resorption	
of	DBBM	as	part	of	the	remodeling	process	was	earlier	suggested	
(Zitzmann,	 Scharer,	 Marinello,	 Schupbach,	 &	 Berglundh,	 2001).	
We	have	determined	the	DBBM	volume	and	also	analyzed	the	size	
distribution	 of	 all	 three	 groups	 of	 DBBM	 particles—the	 control,	
LPS,	and	Ceridust	group.	Independent	of	the	severe	inflammatory	
reaction,	we	 found	 no	 statistical	 changes	 in	 the	DBBM	 volume.	
Nevertheless,	there	was	a	trend	that	inflammation	causes	a	looser	
distribution	of	DBBM	particles	 in	 the	augmented	 site,	 likely	due	
to	 an	 edema	 and	 not	 osteoclast	 activity.	More	 relevant	 are	 our	
findings	 that	 the	 characteristic	 size	distribution	of	DBBM	 in	 the	
mouse	 calvaria	 with	 the	 majority	 of	 particles	 ranging	 between	
0.001 mm3	 to	more	than	0.1	mm3	was	not	considerably	changed	
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(b)
F I G U R E  7  Deproteinized	bovine	bone	mineral	(DBBM)	shows	no	signs	of	resorption	irrespective	of	inflammatory	condition.	The	high	
magnification	shows	the	DBBM	particles	in	controls	and	in	the	inflammatory	LPS	and	Ceridust	group.	No	signs	of	resorption	are	visible	on	
the	surface	of	DBBM	particles	independent	of	the	inflammation	induced,	by	LPS	or	Ceridust




However,	 our	 mouse	 augmentation	 model	 has	 limitations	 as	
is	 does	 not	 represent	 long‐term	 chronic	 inflammation	 and	 also	
DBBM	 in	 the	 soft	 tissue	 of	 the	 oral	mucosa	may	 behave	 differ-
ently	than	in	the	calvaria	sites.	The	present	model	represents	an	





inflammation	were	noticed.	 It	 can	be	 suggested	 that	 at	 the	 time	
of	 tissue	 harvesting,	 the	 inflammation	 had	 ceased	 and	 regen-
eration	 took	 over.	 This	 is	 also	why	 the	 number	 of	 inflammatory	
cells	could	not	be	quantified.	The	present	model	does	not	reflect	
the	 resorption	 pattern	 that	 has	 been	 observed	 using	 other	 ani-
mal	models	(Busenlechner	et	al.,	2012;	Gruber,	2019)	or	in	clinical	
situations	 of	 chronic	 inflammation	 and	 inflammatory	 osteolysis.	
Consequently,	the	effects	of	chronic	inflammation	on	DBBM	need	
to	be	further	evaluated.	Moreover,	wound	dehiscence,	as	was	seen	




were	 stabilized	 only	 by	 the	 elevated	 periosteum;	 therefore,	 we	
cannot	 rule	out	 that	micro‐movements	might	have	displaced	 the	
biomaterial	 affecting	 the	 	 graft	 consolidation.	However,	 the	 pri-
mary	endpoint	was	related	to	the	possible	graft	resorption	under	
inflammatory	 conditions	 and	 in	 this	 sense	 the	histology	 support	
our	 findings.	 There	 is	 thus	 a	 demand	 to	 study	 the	 behaviour	 of	
DBBM	 in	 larger	 preclinical	 models	 under	 chronic	 inflammatory	
conditions.	
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